Molbio Diagnostics Invests $30 Million in OptraSCAN to Revolutionize Digital Pathology

BioNTech Acquires Chinese Oncology Firm Biotheus for $950M

The Care and Protection of Children Trust

CPCT Launches Groundbreaking Initiative to Provide Lifelong Free Treatment for Children with Spinal Muscular Atrophy (SMA) in Karnataka

Early Comprehensive Genomic Profiling Improves Cancer Treatment Outcomes, Study Shows

EMA Reverses Decision, Recommends Limited Approval for Eisai and Biogen’s Alzheimer’s Drug Leqembi

Exact Sciences Unveils Advances in Multi-Cancer Early Detection with Cancerguard™ Test

MSD and LaNova Medicines Enter Exclusive Global License Agreement for Novel Cancer Therapy, LM-299

Promising CAR T Cell Therapies from BMS and Cabaletta Bio Show Potential for Durable Remission in Severe Lupus

FDA Grants Accelerated Approval to PTC Therapeutics' KEBILIDI™, the First Gene Therapy for AADC Deficiency in the U.S.

Association for Molecular Pathology Publishes Joint Consensus Report on SARS-CoV-2 Genomic Surveillance for Hospitals and Public Health Laboratories

Philips India Unveils Advanced Azurion Imaging System to Revolutionize Cardiac and Neurovascular Care

Tempus AI Study Highlights Benefits of Dual RNA and DNA Sequencing for Advanced Lung Cancer

Ontada and Datavant Partner to Expand Access to Real-World Oncology Data for Accelerated Cancer Innovation

Tempus AI and Flatiron Health Partner to Integrate Genomic Testing into OncoEMR for Enhanced Oncology Care

Flare Therapeutics and Roche Forge Strategic Partnership to Discover Precision Oncology Therapies Targeting Transcription Factors

Home
/
insight
/
details

Advancements and Applications of Wearable Technology in Precision Healthcare

NextEdge Admin

18 Apr 2024

3 min 53 sec

Wearable technology, commonly known as wearables have a promising future in clinical settings, expanding patient-specific measures and contributing to the evolution of precision health. By leveraging wearable technology alongside comprehensive digital health interventions, healthcare systems can enhance diagnosis and improve patient engagement.

Wearables play a pivotal role in the proactive management of conditions like hypertension and diabetes. From continuous glucose monitoring to real-time blood pressure tracking, these devices empower individuals with valuable insights, fostering informed decisions for a healthier and more personalized approach to wellness.

The “FreeStyle Libre system” developed by Abbott, represents a significant advancement in continuous glucose monitoring (CGM) technology for individuals with diabetes through a subcutaneous sensor, offering real-time data without routine fingerstick. This system is suitable for adults, children over four years old, and pregnant women with gestational diabetes. Introduced globally in 2014 and available in India since November 2020, it has positively impacted glucose control, reducing hyperglycemia and hypoglycemia, thus enhancing the quality of life for over 2.5 million users worldwide.

Medtronic presents two prominent CGM systems—the Guardian Connect and MiniMed 670G. Guardian Connect offers continuous glucose monitoring every five minutes, sending data to a mobile device for a week. In contrast, the MiniMed 670G not only monitors glucose but also adjusts basal insulin delivery in real-time, creating a closed-loop insulin delivery system for enhanced diabetes management.

Wearable technology has emerged as a transformative force in the management of hypertension as well.Omron’s HeartGuide, the HEM-6410T, redefines blood pressure monitoring with its wrist-based design using an inflatable belt for oscillometric measurement. This clock-sized device allows on-demand and programmable measurements, offering a 10-14 day battery life.

Applanation tonometry-based devices, like Health STATS International’s, enable continuous monitoring via arterial tonometry, facilitating noninvasive measurements for monitoring nocturnal blood pressure and hypertensive peaks.

Wearable cuffless devices, such as CareUp’s smartWatch, leverage photoplethysmography (PPG) for non-ambulatory blood pressure solutions. The integration of PPG into smartphone applications further expands the potential for remote monitoring, with companies exploring this avenue for convenient and accessible blood pressure measurement.

Looking ahead, the future of wearables in healthcare diagnosis is promising. Advancements in sensor technology and data analytics will enable the development of new digital biomarkers for disease diagnosis, progression tracking, and treatment response. Wearables have the potential to democratize healthcare by providing access to remote monitoring and personalized interventions, particularly for underserved populations.